Ikena Oncology Inc. (IKNA): Earnings growth forecast for next year

Corporate company logo of Ikena (IKNA)

Does the development of Ikena Oncology, Inc. (IKNA) depend on economic cycles? The projected net profit growth rate for n+1 demonstrates the business's resilience to macro shocks, where -50.20 determines the current status of the parameter. The precision oncology model guarantees high scalability and margins upon drug approval. However, the risk of clinical trial failure and a high cash burn rate create a need for new equity offerings.

Ikena Oncology Inc. (IKNA): Earnings growth forecast for next year from 07/04/2022 to 08/09/2025

Analytical breakdowns for Ikena Oncology Inc. (IKNA)

- share price and consensus valuation forecast:
Basic company analysis:Ikena Oncology Inc.
Core merchandise of Ikena Oncology

For Ikena Oncology, Inc. (IKNA), which develops patent-protected oncology drugs with long life cycles, the balance of institutional demand is determined by consensus earnings forecasts. By analyzing the projected EPS dynamics for year n+1, an investor can see aggregated market expectations regarding future revenues, which helps avoid overpaying for the asset during isolated analyst valuation revisions.

Competitor analysis for Ikena Oncology, Inc.

ONC (BeiGene Ltd) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Therapeutics HALO|Net earnings per share growth forecast for next year Revolution Medicines, Inc. (RVMD)|Earnings growth forecast for next year Ascentage Pharma Group International (AAPG)|Earnings growth forecast for next year CGON (CG Oncology Inc)|Expected earnings per share trend next year URGN|bicara.com - Earnings growth forecast for next year|Expected earnings per share trend next year PSNL (personalis.com)|Erasca Inc (ERAS) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Delcath Systems|YMAB (YmAbs) - Earnings growth forecast for next year|AURA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Candel Therapeutics, Inc. (CADL)|Earnings growth forecast for next year Accuray (ARAY)|Net earnings per share growth forecast for next year SELLAS Life Sciences Group Inc. SLS|Actuate Therapeutics, Inc (ACTU) - Expected net earnings per share growth next year|CTOR - Net earnings per share growth forecast for next year|HURA: Net earnings per share growth forecast for next year|TARA (Protara) - Expected earnings per share growth for next year|Fate Therapeutics, Inc. - Expected earnings per share trend next year|WHWK (aadibio.com) - Earnings growth forecast for next year|TCRX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Champions Oncology (CSBR)|XBiotech - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year CEL-SCI CVM|Consensus forecast of earnings per share growth for next year OS Therapies (OSTX)|Radiopharm Theranostics Limited - Earnings growth forecast for next year|Expected net earnings per share growth next year Artiva Biotherapeutics|ANL (adlainortye.com) - Expected earnings per share growth for next year|Expected earnings per share growth for next year Veru Pharma|TPST (Tempest Therapeutics Inc) - Earnings growth forecast for next year|Xilio Therapeutics, Inc. (XLO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Enochian BioSciences (RENB)|MURA: Net earnings per share change forecast for next year|Earnings growth forecast for next year KAPA (kairospharma.com)|Consensus forecast of earnings per share growth for next year OnKure (OKUR)|CytoMed Therapeutics Ltd - Earnings growth forecast for next year|curis.com (CRIS) - Expected earnings per share growth for next year|Apollomics Corp (APLM) - Net earnings per share growth forecast for next year|Tharimmune - Expected earnings per share trend next year|ADVB (Advanced Biomed Corp) - Earnings growth forecast for next year|Expected earnings per share growth for next year Genprex, Inc (GNPX)|Earnings growth forecast for next year CLDI|SBFM: Net earnings per share change forecast for next year|Earnings growth forecast for next year XBIO (xeneticbio.com)|Earnings growth forecast for next year Salarius Pharmaceuticals Inc SLRX|purple-biotech.com - Earnings growth forecast for next year|Expected net earnings per share growth next year American Oncology Network, Inc.|BGNE: Earnings growth forecast for next year|Expected earnings per share growth for next year checkpointtx.com|Net earnings per share growth forecast for next year Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year NTBL|Earnings growth forecast for next year Viracta Therapeutics Inc. (VIRX)|Net earnings per share growth forecast for next year MorphoSys Inc MOR|Expected earnings per share trend next year NAYA|AAPGV: Expected earnings per share growth for next year